Ascletis Appoints Dr. Lindi Tan as Chief Financial Officer

HANGZHOU and SHAOXING, China, Nov. 11, 2018 /PRNewswire/ — Ascletis Pharma Inc. (1672.HK) , a commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr. Lindi Tan joins…

Source: https://www.prnewswire.com:443/news-releases/ascletis-appoints-dr-lindi-tan-as-chief-financial-officer-300747400.html

About the Author

has written 39670 stories on this site.

Copyright © 2010 Business and Corporate News.